A
Atossa Therapeutics (ATOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
- USD0.83
- USD0.83
- USD0.79
- USD1.66
- -16.10%
- --
- 724.51k
- 661.10k
- 107M
- 0.55
- -28.80%
Stock News
4 hours ago
Trump says U.S. has launched attack on Iran nuclear sites as investors brace for ‘unpredictable spillovers’ across markets
MarketWatch
4 hours ago
CRWD, PANW, and SentinelOne Get Set to Secure Cybersecurity Market
Yahoo
5 hours ago
Boeing Deserves A Little More Love (Rating Upgrade)
SeekingAlpha
yesterday
Republican Party has nearly five times more cash on hand than the Democrats
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
